Hematology Diagnostics Market

Hematology Diagnostics Market (Product Type: Hematology Instruments and Hematology Consumables; and End-user: Diagnostic Laboratories, Hospitals & Clinics, Academic Institutes, and Others) - Global Industry Analysis, Size, Share, Volume, Growth, Trends, and Forecast, 2023-2031

Hematology Diagnostics Market Outlook 2031

  • The global industry was valued at US$ 4.6 Bn in 2022
  • It is estimated to grow at a CAGR of 5.6% from 2023 to 2031 and reach US$ 7.6 Bn by the end of 2031

Analyst Viewpoint

Surge in prevalence of blood-related disorders and technological advancements in testing procedures are propelling the hematology diagnostics market size. Fully automated laboratory hematology analyzers are gaining traction among end-users as they offer streamlined workflows, increased efficiency, and enhanced accuracy in blood analysis.

Governments in various countries are investing in the development of healthcare infrastructure, thereby offering lucrative hematology diagnostics market opportunities to vendors. Comprehensive and user-friendly platforms along with advanced hematology diagnostic tests are gaining popularity among end-users. Vendors are addressing the varied demands of healthcare professionals, fostering long-term relationships, and establishing a strong market position.

Hematology Diagnostics Market

Market Introduction

Hematology is defined as the diagnostic classification of blood cells and the subsequent identification of blood-forming organ and blood disease abnormalities. The numbers of WBC, RBC, and platelets are all computed. The study of hematologic diseases involves disease monitoring, prognosis, diagnosis, and screening.

Hematology testing devices have made significant strides in their evolution, progressing from diagnosing and monitoring illnesses to conducting blood cell examinations and counts. Automation has further advanced to detect microscopic cell populations in order to diagnose rare blood illnesses. The use of automation has led to a decline in the need for labor and the availability of faster results.

Automation of the hematological assessment procedure has been achieved through various technological approaches, including electrical impedance, flow cytometry, and fluorescence flow, enabling more efficient and accurate blood cell analysis. The convergence of these technologies has increased test yield and productivity in the global hematology diagnostics industry. The number of tests performed or test volume is predicted to increase due to technological advancements in disease detection. This, in turn, is propelling the hematology diagnostics market progress.

Surge in Prevalence of Blood-related Disorders Fueling Hematology Diagnostics Market Expansion

Rise in awareness regarding blood-related disorders is boosting demand for specialized hematology lab services. According to the Leukemia & Lymphoma Society, in the U.S., one person is diagnosed with blood cancer every three minutes. Over 173,000 people in the country were expected to be diagnosed with leukemia, lymphoma, or myeloma by 2022. Leukemia, lymphoma, and myeloma were projected to account for more than 10.2% of the 1.7 million new cancer cases diagnosed In the U.S. in 2022. Over 1.3 million people in the country are estimated to have leukemia, lymphoma, or myeloma, or to be in remission.

Rise in cases of various blood disorders, such as anemia, thalassemia, and hemophilia, is augmenting the hematology diagnostics market value. According to National Institutes of Health (NIH), anemia affects around 29% of women and 38% of pregnant women each year. Furthermore, hematologic tests can now identify diabetes, hypotension, and hypoglycemia, all of which are marked by elevated blood glucose levels. This makes them increasingly popular in diabetic-heavy countries.

Technological Advancements in Testing Procedures Bolstering Hematology Diagnostics Market Development

The blood transferrin receptor test, which was developed recently, allows for more accurate blood analysis for the determination of iron levels in the patient population. Serum ferritin, a 480 kDa multisubunit protein, represents the body's iron storage pool. A drop in serum ferritin level frequently indicates that iron stores have been exhausted. Iron deficiency anemia has become easily distinguishable from chronic disease anemia using serum transferrin receptor testing. Upon comparison to earlier diagnostic approaches, this technology has made hematology diagnostics more accessible and economical.

A newly discovered strain of human herpesvirus has been outlined to play a crucial role in myeloma, a cancer of the cell plasma. Additional thrombotic risk factors have also been identified, leading to more accurate diagnoses. Factor V and prothrombin gene mutations, and hyperhomocysteinaemia are all classified as crucial risk factors. Modern DNA probe arrays can also potentially allow rapid automated detection of mutations. Antisense therapy, ribozyme technology, and other cutting-edge hematology diagnostic techniques have also been developed in the market. Such developments are expected to spur the hematology diagnostics market growth in the near future.

Regional Outlook

According to the latest hematology diagnostics market forecast, North America is expected to hold largest share from 2023 to 2031. High prevalence of blood-related diseases is fueling the market dynamics of the region. According to The Centers for Disease Control and Prevention (CDC), Sickle Cell Disease (SCD) affects approximately 100,000 people in the U.S. SCD occurs among about 1 out of every 365 Black or African-American births.

The industry in Asia Pacific is projected to grow at the fastest rate during the forecast period. Hemoglobinopathies are the most common genetic disorders among people living in Southeast Asia. In Eastern Asia, alfa and beta thalassemia cases are rather common. Thus, rise in cases of hemoglobinopathies is driving the market statistics in Asia Pacific.

Analysis of Key Players

Major hematology diagnostics companies are embracing automation and advanced technologies, such as artificial intelligence and machine learning, to improve the efficiency and accuracy of hematological diagnostics. They are also collaborating with healthcare institutions, research organizations, and industry stakeholders to increase their hematology diagnostics market share.

Abbott, Sysmex Corporation, F. Hoffmann-La Roche Ltd., Beckman Coulter, Inc., Bio-Rad Laboratories, Inc., Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Siemens Healthineers AG, Horiba, Ltd., HemoCue AB, and Danaher Corporation are key entities operating in this market.

Each of these players has been profiled in the hematology diagnostics market report based on parameters such as company overview, business strategies, financial overview, product portfolio, and business segments.

Key Developments

  • In August 2023, Abbott’s Alinity H-Series hematology system gained 510(k) approval from the U.S. Food and Drug Administration. The device can handle up to 119 full blood count tests per hour and can be linked to current core laboratory processes. It also enables hands-free automatic maintenance and configurable reports and rules for systems.
  • In July 2022, Sysmex Corporation introduced new sample transportation system modules that may be attached to the XR-Series Automated Hematology Analyzer (XR-Series), the company's flagship hematology model. The three modules, which include sample sorting, sample archiving, and automated transportation of quality control and cleaning products, help increase the automation and efficiency of clinical testing operations.

Hematology Diagnostics Market Snapshot

Attribute Detail
Market Value in 2022 (Base Year) US$ 4.6 Bn
Market Forecast Value in 2031 US$ 7.6 Bn
Growth Rate (CAGR) 5.6%
Forecast Period 2023 to 2031
Historical Data Available for 2021
Quantitative Units US$ Bn for Value
Market Analysis Qualitative analysis includes drivers, restraints, opportunities, key trends, key market indicators, Porter’s Five Forces analysis, value chain analysis, and SWOT analysis. Furthermore, at the regional level, the qualitative analysis includes key trends, price trends, and key supplier analysis.
Competition Landscape
  • Prominent Players – Competition Dashboard and Revenue Share Analysis, 2023
  • Company Profiles (Details – Company Overview, Sales Area/Geographical Presence, Revenue, Strategy & Business Overview)
Format Electronic (PDF) + Excel
Regions Covered
  • North America
  • Latin America
  • Asia Pacific
  • Europe
  • Middle East & Africa
Countries Covered
  • U.S.
  • Canada
  • Germany
  • U.K.
  • France
  • Spain
  • Italy
  • Russia and CIS
  • Japan
  • China
  • India
  • ASEAN
  • Brazil
  • Mexico
  • GCC
  • South Africa
Market Segmentatio
  • Product Type
    • Hematology Instruments
      • Hematology Analyzers
        • Fully-automated Hematology Analyzers
        • Semi-automated Hematology Analyzers
      • Flow Cytometers
      • Others
    • Hematology Consumables
      • Reagents
      • Stains
      • Controls & Calibrators
      • Others
  • End-user
    • Diagnostic Laboratories
    • Hospitals & Clinics
    • Academic Institutes
    • Others
Companies Profiled
  • Abbott
  • Sysmex Corporation
  • F. Hoffmann-La Roche Ltd.
  • Beckman Coulter, Inc.
  • Bio-Rad Laboratories, Inc.
  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • Siemens Healthineers AG
  • Horiba, Ltd.
  • HemoCue AB
  • Danaher Corporation
Customization Scope Available upon Request
Pricing Available upon Request

Frequently Asked Questions

How big was the hematology diagnostics market in 2022?

It was valued at US$ 4.6 Bn in 2022

How is the hematology diagnostics business expected to grow by 2031?

It is projected to grow at a CAGR of 5.6% from 2023 to 2031

What are the key factors driving the demand for hematology diagnostics?

Surge in prevalence of blood-related disorders and technological advancements in testing procedures

Which end-user segment held the largest share in the hematology diagnostics industry in 2022?

The diagnostic laboratories end-user segment held largest share in 2022

Which was the major region in the hematology diagnostics landscape in 2022?

North America held largest share in 2022

Who are the key hematology diagnostics manufacturers?

Abbott, Sysmex Corporation, F. Hoffmann-La Roche Ltd., Beckman Coulter, Inc., Bio-Rad Laboratories, Inc., Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Siemens Healthineers AG, Horiba, Ltd., HemoCue AB, and Danaher Corporation

1. Preface

    1.1. Market Definition and Scope

    1.2. Market Segmentation

    1.3. Key Research Objectives

    1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Hematology Diagnostics Market

4. Market Overview

    4.1. Introduction

        4.1.1. Product Definition

        4.1.2. Industry Evolution/Developments

    4.2. Overview

    4.3. Market Dynamics

        4.3.1. Drivers

        4.3.2. Restraints

        4.3.3. Opportunities

    4.4. Global Hematology Diagnostics Market Analysis and Forecast, 2023–2031

5. Key Insights

    5.1. Pipeline Analysis

    5.2. Key Product/Brand Analysis

    5.3. Key Mergers & Acquisitions

    5.4. COVID-19 Pandemic Impact on Industry

6. Global Hematology Diagnostics Market Analysis and Forecast, by Product Type

    6.1. Introduction & Definition

    6.2. Key Findings/Developments

    6.3. Market Value Forecast, by Product Type, 2023–2031

        6.3.1. Hematology Instruments

            6.3.1.1. Hematology Analyzers

                6.3.1.1.1. Fully-automated Hematology Analyzers

                6.3.1.1.2. Semi-automated Hematology Analyzers

            6.3.1.2. Flow Cytometers

            6.3.1.3. Others

        6.3.2. Hematology Consumables

            6.3.2.1. Reagents

            6.3.2.2. Stains

            6.3.2.3. Controls & Calibrators

            6.3.2.4. Others

    6.4. Market Attractiveness Analysis, by Product Type

7. Global Hematology Diagnostics Market Analysis and Forecast, by End-user

    7.1. Introduction & Definition

    7.2. Key Findings/Developments

    7.3. Market Value Forecast, by End-user, 2023–2031

        7.3.1. Diagnostic Laboratories

        7.3.2. Hospitals & Clinics

        7.3.3. Academic Institutes

        7.3.4. Others

    7.4. Market Attractiveness Analysis, by End-user

8. Global Hematology Diagnostics Market Analysis and Forecast, by Region

    8.1. Key Findings

    8.2. Market Value Forecast, by Region, 2023–2031

        8.2.1. North America

        8.2.2. Europe

        8.2.3. Asia Pacific

        8.2.4. Latin America

        8.2.5. Middle East & Africa

    8.3. Market Attractiveness Analysis, by Region

9. North America Hematology Diagnostics Market Analysis and Forecast

    9.1. Introduction

    9.2. Key Findings

    9.3. Market Value Forecast, by Product Type, 2023–2031

        9.3.1. Hematology Instruments

            9.3.1.1. Hematology Analyzers

                9.3.1.1.1. Fully-automated Hematology Analyzers

                9.3.1.1.2. Semi-automated Hematology Analyzers

            9.3.1.2. Flow Cytometers

            9.3.1.3. Others

        9.3.2. Hematology Consumables

            9.3.2.1. Reagents

            9.3.2.2. Stains

            9.3.2.3. Controls & Calibrators

            9.3.2.4. Others

    9.4. Market Value Forecast, by End-user, 2023–2031

        9.4.1. Diagnostic Laboratories

        9.4.2. Hospitals & Clinics

        9.4.3. Academic Institutes

    9.5. Market Value Forecast, by Country, 2023–2031

        9.5.1. U.S.

        9.5.2. Canada

    9.6. Market Attractiveness Analysis

        9.6.1. By Product Type

        9.6.2. By End-user

        9.6.3. By Country

10. Europe Hematology Diagnostics Market Analysis and Forecast

    10.1. Introduction

    10.2. Key Findings

    10.3. Market Value Forecast, by Product Type, 2023–2031

        10.3.1. Hematology Instruments

            10.3.1.1. Hematology Analyzers

                10.3.1.1.1. Fully-automated Hematology Analyzers

                10.3.1.1.2. Semi-automated Hematology Analyzers

            10.3.1.2. Flow Cytometers

            10.3.1.3. Others

        10.3.2. Hematology Consumables

            10.3.2.1. Reagents

            10.3.2.2. Stains

            10.3.2.3. Controls & Calibrators

            10.3.2.4. Others

    10.4. Market Value Forecast, by End-user, 2023–2031

        10.4.1. Diagnostic Laboratories

        10.4.2. Hospitals & Clinics

        10.4.3. Academic Institutes

        10.4.4. Others

    10.5. Market Value Forecast, by Country/Sub-region, 2023–2031

        10.5.1. Germany

        10.5.2. U.K.

        10.5.3. France

        10.5.4. Italy

        10.5.5. Spain

        10.5.6. Rest of Europe

    10.6. Market Attractiveness Analysis

        10.6.1. By Product Type

        10.6.2. By End-user

        10.6.3. By Country/Sub-region

11. Asia Pacific Hematology Diagnostics Market Analysis and Forecast

    11.1. Introduction

    11.2. Key Findings

    11.3. Market Value Forecast, by Product Type, 2023–2031

        11.3.1. Hematology Instruments

            11.3.1.1. Hematology Analyzers

                11.3.1.1.1. Fully-automated Hematology Analyzers

                11.3.1.1.2. Semi-automated Hematology Analyzers

            11.3.1.2. Flow Cytometers

            11.3.1.3. Others

        11.3.2. Hematology Consumables

            11.3.2.1. Reagents

            11.3.2.2. Stains

            11.3.2.3. Controls & Calibrators

            11.3.2.4. Others

    11.4. Market Value Forecast, by End-user, 2023–2031

        11.4.1. Diagnostic Laboratories

        11.4.2. Hospitals & Clinics

        11.4.3. Academic Institutes

        11.4.4. Others

    11.5. Market Value Forecast, by Country/Sub-region, 2023–2031

        11.5.1. China

        11.5.2. Japan

        11.5.3. India

        11.5.4. Australia & New Zealand

        11.5.5. Rest of Asia Pacific

    11.6. Market Attractiveness Analysis

        11.6.1. By Product Type

        11.6.2. By End-user

        11.6.3. By Country/Sub-region

12. Latin America Hematology Diagnostics Market Analysis and Forecast

    12.1. Introduction

    12.2. Key Findings

    12.3. Market Value Forecast, by Product Type, 2023–2031

        12.3.1. Hematology Instruments

            12.3.1.1. Hematology Analyzers

                12.3.1.1.1. Fully-automated Hematology Analyzers

                12.3.1.1.2. Semi-automated Hematology Analyzers

            12.3.1.2. Flow Cytometers

            12.3.1.3. Others

        12.3.2. Hematology Consumables

            12.3.2.1. Reagents

            12.3.2.2. Stains

            12.3.2.3. Controls & Calibrators

            12.3.2.4. Others

    12.4. Market Value Forecast, by End-user, 2023–2031

        12.4.1. Diagnostic Laboratories

        12.4.2. Hospitals & Clinics

        12.4.3. Academic Institutes

        12.4.4. Others

    12.5. Market Value Forecast, by Country/Sub-region, 2023–2031

        12.5.1. Brazil

        12.5.2. Mexico

        12.5.3. Rest of Latin America

    12.6. Market Attractiveness Analysis

        12.6.1. By Product Type

        12.6.2. By End-user

        12.6.3. By Country/Sub-region

13. Middle East & Africa Hematology Diagnostics Market Analysis and Forecast

    13.1. Introduction

    13.2. Key Findings

    13.3. Market Value Forecast, by Product Type, 2023–2031

        13.3.1. Hematology Instruments

            13.3.1.1. Hematology Analyzers

                13.3.1.1.1. Fully-automated Hematology Analyzers

                13.3.1.1.2. Semi-automated Hematology Analyzers

            13.3.1.2. Flow Cytometers

            13.3.1.3. Others

        13.3.2. Hematology Consumables

            13.3.2.1. Reagents

            13.3.2.2. Stains

            13.3.2.3. Controls & Calibrators

            13.3.2.4. Others

    13.4. Market Value Forecast, by End-user, 2023–2031

        13.4.1. Diagnostic Laboratories

        13.4.2. Hospitals & Clinics

        13.4.3. Academic Institutes

        13.4.4. Others

    13.5. Market Value Forecast, by Country/Sub-region, 2023–2031

        13.5.1. GCC Countries

        13.5.2. South Africa

        13.5.3. Rest of Middle East & Africa

    13.6. Market Attractiveness Analysis

        13.6.1. By Product Type

        13.6.2. By End-user

        13.6.3. By Country/Sub-region

14. Competition Landscape

    14.1. Market Player - Competitive Matrix (by Tier and Size of Companies)

    14.2. Market Share Analysis, by Company (2022)

    14.3. Company Profiles

        14.3.1. Abbott

            14.3.1.1. Company Overview

            14.3.1.2. Product Portfolio

            14.3.1.3. SWOT Analysis

            14.3.1.4. Financial Overview

            14.3.1.5. Strategic Overview

        14.3.2. Sysmex Corporation

            14.3.2.1. Company Overview

            14.3.2.2. Product Portfolio

            14.3.2.3. SWOT Analysis

            14.3.2.4. Financial Overview

            14.3.2.5. Strategic Overview

        14.3.3. F. Hoffmann-La Roche Ltd.

            14.3.3.1. Company Overview

            14.3.3.2. Product Portfolio

            14.3.3.3. SWOT Analysis

            14.3.3.4. Financial Overview

            14.3.3.5. Strategic Overview

        14.3.4. Beckman Coulter, Inc.

            14.3.4.1. Company Overview

            14.3.4.2. Product Portfolio

            14.3.4.3. SWOT Analysis

            14.3.4.4. Financial Overview

            14.3.4.5. Strategic Overview

        14.3.5. Bio-Rad Laboratories, Inc.

            14.3.5.1. Company Overview

            14.3.5.2. Product Portfolio

            14.3.5.3. SWOT Analysis

            14.3.5.4. Financial Overview

            14.3.5.5. Strategic Overview

        14.3.6. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.

            14.3.6.1. Company Overview

            14.3.6.2. Product Portfolio

            14.3.6.3. SWOT Analysis

            14.3.6.4. Financial Overview

            14.3.6.5. Strategic Overview

        14.3.7. Siemens Healthineers AG

            14.3.7.1. Company Overview

            14.3.7.2. Product Portfolio

            14.3.7.3. SWOT Analysis

            14.3.7.4. Financial Overview

            14.3.7.5. Strategic Overview

        14.3.8. Horiba, Ltd.

            14.3.8.1. Company Overview

            14.3.8.2. Product Portfolio

            14.3.8.3. SWOT Analysis

            14.3.8.4. Financial Overview

            14.3.8.5. Strategic Overview

        14.3.9. HemoCue AB

            14.3.9.1. Company Overview

            14.3.9.2. Product Portfolio

            14.3.9.3. SWOT Analysis

            14.3.9.4. Financial Overview

            14.3.9.5. Strategic Overview

        14.3.10. Danaher Corporation

            14.3.10.1. Company Overview

            14.3.10.2. Product Portfolio

            14.3.10.3. SWOT Analysis

            14.3.10.4. Financial Overview

            14.3.10.5. Strategic Overview

List of Tables

Table 01: Global Hematology Diagnostics Market Size (US$ Mn) Forecast, by Product Type, 2023–2031

Table 02: Global Hematology Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2023–2031

Table 03: Global Hematology Diagnostics Market Size (US$ Mn) Forecast, by Region, 2023–2031

Table 04: North America Hematology Diagnostics Market Size (US$ Mn) Forecast, by Country, 2023–2031

Table 05: North America Hematology Diagnostics Market Size (US$ Mn) Forecast, by Product Type, 2023–2031

Table 06: North America Hematology Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2023–2031

Table 07: Europe Hematology Diagnostics Market Size (US$ Mn) Forecast, by Country/Sub-region, 2023–2031

Table 8: Europe Hematology Diagnostics Market Size (US$ Mn) Forecast, by Product Type, 2023–2031

Table 9: Europe Hematology Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2023–2031

Table 10: Asia Pacific Hematology Diagnostics Market Size (US$ Mn) Forecast, by Country/Sub-region, 2023–2031

Table 11: Asia Pacific Hematology Diagnostics Market Size (US$ Mn) Forecast, by Product Type, 2023–2031

Table 12: Asia Pacific Hematology Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2023–2031

Table 13: Latin America Hematology Diagnostics Market Size (US$ Mn) Forecast, by Country/Sub-region, 2023–2031

Table 14: Latin America Hematology Diagnostics Market Size (US$ Mn) Forecast, by Product Type, 2023–2031

Table 15: Latin America Hematology Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2023–2031

Table 16: Middle East & Africa Hematology Diagnostics Market Size (US$ Mn) Forecast, by Country/Sub-region, 2023–2031

Table 17: Middle East & Africa Hematology Diagnostics Market Size (US$ Mn) Forecast, by Product Type, 2023–2031

Table 18: Middle East & Africa Hematology Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2023–2031

List of Figures

Figure 01: Global Hematology Diagnostics Market Size (US$ Mn) and Distribution (%), by Region, 2023 and 2031

Figure 02: Global Hematology Diagnostics Market Revenue (US$ Mn), by Product Type, 2022

Figure 03: Global Hematology Diagnostics Market Value Share, by Product Type, 2022

Figure 04: Global Hematology Diagnostics Market Revenue (US$ Mn), by End-user, 2022

Figure 05: Global Hematology Diagnostics Market Value Share, by End-user, 2022

Figure 06: Global Hematology Diagnostics Market Value Share, by Region, 2022

Figure 07: Global Hematology Diagnostics Market Value (US$ Mn) Forecast, 2023–2031

Figure 8: Global Hematology Diagnostics Market Value Share Analysis, by Product Type, 2023 and 2031

Figure 9: Global Hematology Diagnostics Market Attractiveness Analysis, by Product Type, 2022-2031

Figure 10: Global Hematology Diagnostics Market Value Share Analysis, by End-user, 2023 and 2031

Figure 11: Global Hematology Diagnostics Market Attractiveness Analysis, by End-user, 2022-2031

Figure 12: Global Hematology Diagnostics Market Value Share Analysis, by Region, 2023 and 2031

Figure 13: Global Hematology Diagnostics Market Attractiveness Analysis, by Region, 2022-2031

Figure 14: North America Hematology Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2023–2031

Figure 15: North America Hematology Diagnostics Market Attractiveness Analysis, by Country, 2023–2031

Figure 16: North America Hematology Diagnostics Market Value Share Analysis, by Country, 2023 and 2031

Figure 17: North America Hematology Diagnostics Market Value Share Analysis, by Product Type, 2023 and 2031

Figure 18: North America Hematology Diagnostics Market Value Share Analysis, by End-user, 2023 and 2031

Figure 19: North America Hematology Diagnostics Market Attractiveness Analysis, by Product Type, 2022–2031

Figure 20: North America Hematology Diagnostics Market Attractiveness Analysis, by End-user, 2022–2031

Figure 21: Europe Hematology Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2023–2031

Figure 22: Europe Hematology Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2023–2031

Figure 23: Europe Hematology Diagnostics Market Value Share Analysis, by Country/Sub-region, 2023 and 2031

Figure 24: Europe Hematology Diagnostics Market Value Share Analysis, by Product Type, 2023 and 2031

Figure 25: Europe Hematology Diagnostics Market Value Share Analysis, by End-user, 2023 and 2031

Figure 26: Europe Hematology Diagnostics Market Attractiveness Analysis, by Product Type, 2022–2031

Figure 27: Europe Hematology Diagnostics Market Attractiveness Analysis, by End-user, 2022–2031

Figure 28: Asia Pacific Hematology Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2023–2031

Figure 29: Asia Pacific Hematology Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2023–2031

Figure 30: Asia Pacific Hematology Diagnostics Market Value Share Analysis, by Country/Sub-region, 2023 and 2031

Figure 31: Asia Pacific Hematology Diagnostics Market Value Share Analysis, by Product Type, 2023 and 2031

Figure 32: Asia Pacific Hematology Diagnostics Market Value Share Analysis, by End-user, 2023 and 2031

Figure 33: Asia Pacific Hematology Diagnostics Market Attractiveness Analysis, by Product Type, 2022–2031

Figure 34: Asia Pacific Hematology Diagnostics Market Attractiveness Analysis, by End-user, 2022–2031

Figure 35: Latin America Hematology Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2023–2031

Figure 36: Latin America Hematology Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2023–2031

Figure 37: Latin America Hematology Diagnostics Market Value Share Analysis, by Country/Sub-region, 2023 and 2031

Figure 38: Latin America Hematology Diagnostics Market Value Share Analysis, by Product Type, 2023 and 2031

Figure 39: Latin America Hematology Diagnostics Market Value Share Analysis, by End-user, 2023 and 2031

Figure 40: Latin America Hematology Diagnostics Market Attractiveness Analysis, by Product Type, 2022–2031

Figure 41: Latin America Hematology Diagnostics Market Attractiveness Analysis, by End-user, 2022–2031

Figure 42: Middle East & Africa Hematology Diagnostics Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2023–2031

Figure 43: Middle East & Africa Hematology Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2023–2031

Figure 44: Middle East & Africa Hematology Diagnostics Market Value Share Analysis, by Country/Sub-region, 2023 and 2031

Figure 45: Middle East & Africa Hematology Diagnostics Market Value Share Analysis, by Product Type, 2023 and 2031

Figure 46: Middle East & Africa Hematology Diagnostics Market Value Share Analysis, by End-user, 2023 and 2031

Figure 47: Middle East & Africa Hematology Diagnostics Market Attractiveness Analysis, by Product Type, 2022–2031

Figure 48: Middle East & Africa Hematology Diagnostics Market Attractiveness Analysis, by End-user, 2022–2031

Copyright © Transparency Market Research, Inc. All Rights reserved